The gold standard of medical research, the randomized controlled trial, has been taking a bit of a beating lately.
An entire issue of the journal Social Science and Medicine was recently devoted to it, with many articles pointing to shortcomings. Others have argued that randomized controlled trials often can’t address the questions that patients and physicians most want answered. I recently wrote about the limitations of the method in studying effectiveness, which is what we care about in real-world situations.
